Sharif Abdelfattah, DPM
Foot & Ankle Surgery · Sullivan, INNPI 1639605637
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 82.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $6,161 and has fallen 98.2% since, to $113 in 2025.
Across 37 payments — averaging $286.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$9K
- Crossroads Orthopedics, LLC$924
- Stryker$686
- Orthofix Medical, Inc.$80
- Kerecis Limited$52
- Averitas Pharma Inc.$20
- plus $94 from 6 others
What the payments were for
- Consulting fees$6,12558%
- Travel & lodging$2,86827%
- Food & beverage$6766%
- Education$9249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 22 | $8,737 |
| Crossroads Orthopedics, LLC | 1 | $924 |
| Stryker | 2 | $686 |
| Orthofix Medical, Inc. | 4 | $80 |
| Kerecis Limited | 1 | $52 |
| Averitas Pharma Inc. | 1 | $20 |
| Vertex | 1 | $18 |
| Amgen | 1 | $18 |
| Solventum Corporation | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InCore Lapidus$1,617
- PRIME SERIES$686
- Trabecular Metal (TM)$325
How this compares
$10,593 in reported general payments places this provider in the 70th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $5,883 |
| Gabapentin | 141 | $2,380 |
| Duloxetine Hcl | 66 | $1,210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 123 | $1,015 |
| Pregabalin | 23 | $835 |
| Gentamicin Sulfate | 13 | $564 |
| Pentoxifylline | 14 | $310 |
| Ketoconazole | 15 | $279 |
| Potassium Chloride | 44 | $276 |
| Levofloxacin | 63 | $243 |
| Terbinafine Hcl | 21 | $241 |
| Ammonium Lactate | 21 | $211 |
| Cephalexin | 23 | $196 |
| Doxycycline Hyclate | 12 | $180 |
| Furosemide | 77 | $174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $15 | $5,88313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 212 foot & ankle surgery providers in Indiana.
Other foot & ankle surgery in Sullivan
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Steven DouthettFort Wayne$153K
- Christopher WintersCarmel$152K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.